Emil Hermansen

Report from the European Myeloma Network on interphase FISH in multiple myeloma and related disorders

F. M. Ross, Hervé Avet‐Loiseau, Geneviève Ameye et al. · Haematologica · 2012 · 322 citations · Full text

Medicine, Hematology, Pathology +15

Improvement in the outcome of invasive fusariosis in the last decade

Márcio Nucci, Kieren A. Marr, Maria J. G. T. Vehreschild et al. · Clinical Microbiology and Infection · 2013 · 192 citations · Full text

Life Sciences, Biology, Microbiology +14

Dual inhibition of DNMTs and EZH2 can overcome both intrinsic and acquired resistance of myeloma cells to IMiDs in a cereblon‐independent manner

Konstantinos Dimopoulos, Alexandra S. Helbo, Helga Fibiger Munch‐Petersen et al. · Molecular Oncology · 2017 · 85 citations · Full text

Medicine, Oncology, Pharmacology +16

The real-world outcomes of multiple myeloma patients treated with daratumumab

Agoston Gyula Szabo, Tobias Wirenfeldt Klausen, Mette Bøegh Levring et al. · PLoS ONE · 2021 · 26 citations · Full text

Medicine, Hematology, Pharmacotherapy +15

Outcome data from >10 000 multiple myeloma patients in the Danish and Swedish national registries

Cecilie Blimark, Annette Juul Vangsted, Tobias Wirenfeldt Klausen et al. · European Journal Of Haematology · 2021 · 15 citations · Full text

Medicine, Oncology, Clinical Epidemiology +14